Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study

J Thaler, G Gastl, T Fluckinger, D Niederwieser… - Annals of …, 1996 - Springer
In a prospective multicenter phase-II trial 80 patients with Philadelphia (Ph)-positive chronic
myelogenous leukemia (CML) were treated with recombinant interferon (IFN) α-2c …
被引用次数：18 相关文章
[PDF] academia.edu

[PDF][PDF] Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study

J Thaler, G Gastl, T Fluckinger, D Niederwieser… - Ann …, 1996 - academia.edu
In a prospective multicenter phase-II trial 80 patients with Philadelphia (Ph)-positive chronic
myelogenous leukemia (CML) were treated with recombinant interferon (IFN) α-2c …

[引用][C] Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study

J THALER, G GASTL, G UTERMANN… - … of hematology (Print …, 1996 - pascal-francis.inist.fr
Interferon alpha-2c therapy of patients with chronic myelogenous leukemia : long-term
results of a multicenter phase-II study CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study

J Thaler, G Gastl, T Fluckinger, D Niederwieser… - Annals of …, 1996 - elibrary.ru
In a prospective multicenter phase-II trial 80 patients with Philadelphia (Ph)-positive chronic
myelogenous leukemia (CML) were treated with recombinant interferon (IFN) α-2c …

Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study. Austrian Biological Response Modifier …

J Thaler, G Gastl, T Fluckinger… - Annals of …, 1996 - pubmed.ncbi.nlm.nih.gov
In a prospective multicenter phase-II trial 80 patients with Philadelphia (Ph)-positive chronic
myelogenous leukemia (CML) were treated with recombinant interferon (IFN) alpha-2c …

[引用][C] Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study. Austrian Biological Response …

J THALER - Ann Hematol, 1996 - cir.nii.ac.jp
Interferon alpha-2c therapy of patients with chronic myelogenous leukemia : long-term results
of a multicenter phase-II study. Austrian Biological Response Modifier (BRM) Study Group …

Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study

J Thaler, G Gastl, T Fluckinger, D Niederwieser… - Annals of …, 1996 - infona.pl
AbstractIn a prospective multicenter phase-II trial 80 patients with Philadelphia (Ph)-positive
chronic myelogenous leukemia (CML) were treated with recombinant interferon (IFN)-2c …

Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study. Austrian Biological Response Modifier …

J Thaler, G Gastl, T Fluckinger, D Niederwieser… - Annals of …, 1996 - europepmc.org
In a prospective multicenter phase-II trial 80 patients with Philadelphia (Ph)-positive chronic
myelogenous leukemia (CML) were treated with recombinant interferon (IFN) alpha-2c …

[引用][C] Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study

J Thaler, G Gastl, T Fluckinger, D Niederwieser… - Annals of …, 1996 - cir.nii.ac.jp
Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results
of a multicenter phase-II study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

[引用][C] Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study

J Thaler, G Gastl, T Fluckinger, D Niederwieser… - Annals of …, 1996 - Springer